tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Charles River reports Q2 adjusted EPS $3.12, consensus $2.50
PremiumThe FlyCharles River reports Q2 adjusted EPS $3.12, consensus $2.50
10d ago
Charles River raises FY25 EPS view to $9.90-$10.30 from $9.30-$9.80
Premium
The Fly
Charles River raises FY25 EPS view to $9.90-$10.30 from $9.30-$9.80
10d ago
Is CRL a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRL a Buy, Before Earnings?
12d ago
Early notable gainers among liquid option names on June 4th
PremiumThe FlyEarly notable gainers among liquid option names on June 4th
2M ago
Charles River, CHDI Foundation extend ongoing drug discovery partnership
Premium
The Fly
Charles River, CHDI Foundation extend ongoing drug discovery partnership
3M ago
Charles River Labs Extends CEO’s Term Amid Shareholder Meeting
Premium
Company Announcements
Charles River Labs Extends CEO’s Term Amid Shareholder Meeting
3M ago
UnitedHealth, Wayfair downgraded: Wall Street’s top analyst calls
PremiumThe FlyUnitedHealth, Wayfair downgraded: Wall Street’s top analyst calls
3M ago
TD upgrades Charles River to Buy on potential for value creation
Premium
The Fly
TD upgrades Charles River to Buy on potential for value creation
3M ago
Unlocking Value: Strategic Divestitures and Market Leadership at Charles River Labs
Premium
Ratings
Unlocking Value: Strategic Divestitures and Market Leadership at Charles River Labs
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100